SANUWAVE director granted 6,215 stock options

SANUWAVE Health director Ian D. Miller received a grant of stock options, giving him the right to acquire 6,215 shares of Common Stock.

Accepted by SEC EDGAR 07/02/2026 - 04:13 PM EDT

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

SANUWAVE Health director Ian D. Miller received a grant of stock options, giving him the right to acquire 6,215 shares of Common Stock. The options have an exercise price of $10.00 per share, were fully vested on the grant date, and expire on June 30, 2031. Following this award, he holds 6,215 derivative securities directly.

Insider Trade Summary

Grant/Award: 6,215 shares

Grant/Award 1 txn

Insider Miller Ian D.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	6,215	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 6,215 contracts (Direct)

Holdings Before and After: Stock Option (right to buy), 0 to 6,215 contracts (Direct)

Footnotes (1)

F1. Options were fully vested at the grant date.

Key Figures

Stock options granted: 6,215 options Exercise price: $10.00 per share Underlying shares: 6,215 shares +2 more

5 metrics

Stock options granted 6,215 options Grant to director Ian D. Miller

Exercise price $10.00 per share Stock option strike price

Underlying shares 6,215 shares Common Stock underlying options

Expiration date June 30, 2031 Option term end

Holdings after transaction 6,215 derivative securities Total options held directly post-grant

Key Terms

Stock Option (right to buy), Grant, award, or other acquisition, Common Stock, derivative securities

4 terms

Stock Option (right to buy) financial

"security_title: Stock Option (right to buy)"

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Common Stock financial

"underlying_security_title: Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

derivative securities financial

"total_shares_following_transaction: 6,215.0000 derivative securities"

Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did SANUWAVE Health (SNWV) report for Ian D. Miller?

SANUWAVE Health reported that director Ian D. Miller received a grant of 6,215 stock options. These options give him the right to buy an equal number of Common Stock shares, providing equity-based compensation aligned with the company’s performance over time.

What is the exercise price of Ian D. Miller’s new SANUWAVE Health (SNWV) stock options?

The stock options granted to Ian D. Miller have an exercise price of $10.00 per share. This means he can purchase SANUWAVE Health Common Stock at $10.00, regardless of the market price when he chooses to exercise, subject to the option terms.

When do Ian D. Miller’s SANUWAVE Health (SNWV) stock options expire?

Ian D. Miller’s stock options expire on June 30, 2031. He can choose to exercise these options any time before that expiration date under the plan’s terms, allowing long-term potential participation in SANUWAVE Health’s share performance.

Were Ian D. Miller’s SANUWAVE Health (SNWV) stock options subject to vesting?

The filing states that Ian D. Miller’s options were fully vested on the grant date. This means he did not need to satisfy additional service or performance conditions before being able to exercise the options, subject to standard plan rules.

How many SANUWAVE Health (SNWV) derivative securities does Ian D. Miller hold after this grant?

After the reported grant, Ian D. Miller holds 6,215 derivative securities directly in the form of stock options. Each option corresponds to one share of Common Stock, reflecting his potential future ownership if he exercises all granted options.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Miller Ian D.

(Last)

(First)

(Middle)

9600 W. 76TH STREET

SUITE 118

(Street)

EDEN PRAIRIE

MINNESOTA

55344

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SANUWAVE Health, Inc. [ SNVW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy)	$10	06/30/2026		A		6,215		⁽¹⁾	06/30/2031	Common Stock	6,215	$0	6,215	D

Explanation of Responses:

1. Options were fully vested at the grant date.

	/s/ Griffin D. Foster, Attorney-in-Fact for Ian D. Miller	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR